Search Results - "BROWN, Nadine M"
-
1
The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones
Published in The Journal of nutrition (01-12-2002)“…Equol [7-hydroxy-3-(4'-hydroxyphenyl)-chroman] is a nonsteroidal estrogen of the isoflavone class. It is exclusively a product of intestinal bacterial…”
Get more information
Journal Article -
2
Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk
Published in The American journal of clinical nutrition (01-11-2011)“…Human and animal studies have produced conflicting results with regard to the effect of soy isoflavones on breast cancer risk. This may be due to differences…”
Get full text
Journal Article -
3
Dietary factors influence production of the soy isoflavone metabolite s-(-)equol in healthy adults
Published in The Journal of nutrition (01-12-2013)“…S-(-)equol, an intestinally derived metabolite of the soy isoflavone daidzein, is proposed to enhance the efficacy of soy diets. Adults differ in their ability…”
Get more information
Journal Article -
4
Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability
Published in The American journal of clinical nutrition (01-08-2002)“…Background: The isoflavones daidzein and genistein occur naturally in most soyfoods, conjugated almost exclusively to sugars. Controversy exists regarding the…”
Get full text
Journal Article -
5
Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans
Published in Food & function (01-03-2014)“…Secoisolariciresinol-diglycoside (SDG), a natural dietary lignan of flaxseeds now available in dietary supplements, is converted by intestinal bacteria to the…”
Get more information
Journal Article -
6
Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements
Published in The Journal of nutrition (01-04-2001)“…The pharmacokinetic behavior of naturally occurring isoflavones has been determined for the first time in healthy adults. We compared plasma kinetics of pure…”
Get more information
Journal Article -
7
S-Equol, a potent ligand for estrogen receptor β, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora
Published in The American journal of clinical nutrition (01-05-2005)“…Background: The discovery of equol in human urine more than 2 decades ago and the finding that it is bacterially derived from daidzin, an isoflavone abundant…”
Get full text
Journal Article -
8
pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers
Published in The American journal of clinical nutrition (01-10-2009)“…BACKGROUND: The nonsteroidal estrogen equol occurs as diastereoisomers, S-(-)equol and R-(+)equol, both of which have significant biological actions…”
Get full text
Journal Article -
9
Animal Models Impacted by Phytoestrogens in Commercial Chow: Implications for Pathways Influenced by Hormones
Published in Laboratory investigation (01-05-2001)“…It is generally not known that most commercial rodent diets are formulated with soy protein and deliver large daily doses of isoflavones to animals throughout…”
Get full text
Journal Article -
10
The Estrogenic Content of Rodent Diets, Bedding, Cages, and Water Bottles and Its Effect on Bisphenol A Studies
Published in Journal of the American Association for Laboratory Animal Science (01-03-2013)“…The lowest observed adverse effect level for bisphenol A (BPA) in mice and rats is currently poorly defined due to inconsistent study designs and results in…”
Get full text
Journal Article -
11
S -(−)equol production is developmentally regulated and related to early diet composition
Published in Nutrition research (New York, N.Y.) (01-05-2014)“…Abstract S -(−)7-hydroxy-3-(4′-hydroxyphenyl)-chroman, or S -(−)equol, a biologically active intestinally derived bacterial metabolite of the soy isoflavones…”
Get full text
Journal Article -
12
The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer
Published in Carcinogenesis (New York) (01-05-2010)“…We describe for the first time the chemopreventive effects of S-(−)equol and R-(+)equol, diastereoisomers with contrasting affinities for estrogen receptors…”
Get full text
Journal Article -
13
Impact of perinatal exposure to equol enantiomers on reproductive development in rodents
Published in Reproductive toxicology (Elmsford, N.Y.) (01-07-2011)“…There is now considerable interest in the intestinally derived soy isoflavone metabolite, equol, which occurs in the enantiomeric forms, S-(−)equol and…”
Get full text
Journal Article -
14
Prenatal TCDD and predisposition to mammary cancer in the rat
Published in Carcinogenesis (New York) (01-09-1998)“…Prenatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was investigated for its potential to predispose to breast cancer. Analysis of mammary gland…”
Get full text
Journal Article -
15
Pharmacokinetics of a Slow-Release Formulation of Soybean Isoflavones in Healthy Postmenopausal Women
Published in Journal of agricultural and food chemistry (23-03-2005)“…Pharmacokinetic studies of soybean isoflavones have shown that following oral ingestion, the two major isoflavones, daidzin and genistin, are hydrolyzed in the…”
Get full text
Journal Article -
16
Xenoestrogens Alter Mammary Gland Differentiation and Cell Proliferation in the Rat
Published in Environmental health perspectives (01-07-1995)“…We investigated mammary gland differentiation and cell proliferation in rats after acute exposure to xenoestrogens. Pubertal female Sprague-Dawley rats…”
Get full text
Journal Article -
17
MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION: Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats
Published in Carcinogenesis (New York) (1996)“…Genistein, a component of soy, was administered to pre-pubertal female Sprague-Dawley CD rats and investigated for chemoprevention against mammary cancer…”
Get full text
Journal Article -
18
Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk1234
Published in The American journal of clinical nutrition (01-10-2011)“…Background: Human and animal studies have produced conflicting results with regard to the effect of soy isoflavones on breast cancer risk. This may be due to…”
Get full text
Journal Article -
19
The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers23
Published in The American journal of clinical nutrition (01-10-2009)“…Background:The nonsteroidal estrogen equol occurs as diastereoisomers, S-()equol and R-(+)equol, both of which have significant biological actions. S-()equol,…”
Get full text
Journal Article -
20
The pharmacokinetic behavior of the soy isoflavone metabolite S-(−)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers1234
Published in The American journal of clinical nutrition (26-08-2009)“…Background: The nonsteroidal estrogen equol occurs as diastereoisomers, S -(−)equol and R -(+)equol, both of which have significant biological actions. S…”
Get full text
Journal Article